Navigation Links
Vitamin D to reduce multiple sclerosis

The researchers at Harvard School of Public Health had found out that the intake of vitamin D might reduce the risk of having multiple// sclerosis (MS) in women. The study said that women who took a vitamin D supplement had a 40% less chance of developing MS than the ones who did not take any such supplements.

Multiple sclerosis is a chronic neurological disease of the central nervous system. There is no cure for this disease but modern day treatment may slow the course of development or give relief from some of the symptoms of this disease.

The Harvard study had looked into the dietary information of more than 185000 women from Nurses’ Health Study and Nurses’ Health Study II. The participants had filled up a questionnaire very four years from 1980 to 1999 that looked into all dietary information, especially their vitamin D intake. When compared with women who did not take the recommended dietary allowance of vitamin D, those who took the highest levels of vitamin intake through vitamin supplements (400 IU per day or more) showed a reduced risk of developing multiple sclerosis. However, there was no association of taking vitamin D through food alone with the onset of the disease.

Reference : http://www.hsph.harvard.edu/press/releases/press01122004a.htl
'"/>




Page: 1

Related medicine news :

1. Vitamin B12 can help in detecting cancers
2. Vitamins-The answer to Heart Disease?
3. Vitamin E, the latest warrior against diabetes
4. Vitamin Shields Brittle Bones
5. B Vitamin protects and lowers toxicity of Arthritis Drug
6. B Vitamin Supplementatoin Saves Money and Lives
7. Eat Vitamin C and stay young
8. Vitamin C for the heart
9. Vitamin B for Hepatitis
10. Vitamins reduce pre-eclampsia
11. Vitamin E useful for Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Vitamin reduce multiple sclerosis

(Date:4/17/2014)... recent papers by a University of Colorado School ... develop treatments or vaccines for Dengue fever, West ... disease-causing flaviviruses. , Jeffrey S. Kieft, PhD, associate ... School of Medicine and an early career scientist ... recently published articles in the scholarly journals ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... Medicine (BUSM) have discovered that the anti-seizure drug ... The findings, reported in the American Journal ... to more effective treatments for alcoholism. , Excessive ... causes of illness and death in the U.S. ... the productivity of workers and necessitating huge health ...
(Date:4/17/2014)... scientists and their partners have found that their proprietary ... transmission of multiple sexually transmitted infections (STIs) in both ... virus 2 (HSV-2), and human papillomavirus (HPV). The USAID-funded ... is effective against multiple strains of HIV, and has ... three viruses of at least eight hours prior to ...
(Date:4/17/2014)... found that India,s shocking rates of suicide are highest ... clinging to tiny smallholdings less than one hectare ... cotton and coffee, that are highly susceptible to global ... previous case studies that point to a crisis in ... of the nation,s economy during the 90s. Researchers say ...
Breaking Medicine News(10 mins):Health News:CU researchers discover target for treating dengue fever 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 2Health News:New evidence of suicide epidemic among India's 'marginalized' farmers 3
... recent surge in,Methicillin-resistant Staphylococcus aureus (MRSA) cases have ... to health care,environments (HA-MRSA), the new community acquired ... and athletic settings(1).,Hospitals concerned about the growing incidence ... new technology that converts alcohol into a nonflammable,vapor, ...
... Nov. 2 RHEI Pharmaceuticals, Inc., a,fully integrated ... the China market, will be presenting, at the,Acumen ... on Monday,November 5, 2007 at 2:20 p.m., eastern. ... for any,company wishing to gain access to the ...
... BRIDGEWATER, Mass., Nov. 2 Pressure,BioSciences, Inc. (Nasdaq: ... Founder, President, and CEO, will present a corporate,overview at ... in New York City on Monday, November 5, 2007 ... at The New York Palace Hotel, New York,City. The ...
... defined as the capacity to perceive, comprehend and regulate one,s ... able to distinguish between emotions and use this information as ... important benefits of developing this type of intelligence is the ... face an ever changing social and cultural world more effectively. ...
... Instruments, Inc.,developer and manufacturer of Mikro-Tip(R) pressure transducer ... of its MPVS,Ultra(TM) P-V system for both small ... simultaneously and continuously measures high-fidelity,left ventricular pressure and ... in size from transgenic mice to domestic livestock. ...
... SEATTLE, Nov. 2 Dendreon Corporation (Nasdaq:,DNDN) will release its ... will host a conference call at 1:30,p.m. PT; 4:30 p.m. ... Access to the discussion may be obtained as follows: ... PT Date: November 15, 2007 ...
Cached Medicine News:Health News:Biomist Inc.: Health Officials Discover New Technology to Kill Superbug MRSA 2Health News:Pressure BioSciences to Present at the Rodman & Renshaw BioFin 9th Annual Healthcare Conference in New York City on November 5th 2Health News:Emotional Intelligence and the use of tobacco and cannabis 2Health News:Millar Instruments Launches Complete Pressure-Volume System for Large and Small Animal Models 2Health News:-Dendreon to Hold Conference Call on Thursday, November 15, 2007 at 4:30 PM ET- 2
(Date:1/15/2014)... , Jan. 15, 2014  Echo Therapeutics, Inc. (Nasdaq: ... its Symphony® CGM System as a non-invasive, wireless continuous ... Doman , Executive Chairman and Interim CEO of Echo ... Tenth Annual Equity Conference. Mr. Doman ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... - India Drug Forecast and Market Analysis ... PharmaPoint: Atopic Dermatitis - India ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a leading ... of severely obese patients, today announced initial results ... selective inhibitor of methionine aminopeptidase 2 (MetAP2), in ... of genetic obesity.  These results showed improvements in ...
Breaking Medicine Technology:Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... Calif., May 5, 2011 Rigel Pharmaceuticals, Inc. (Nasdaq: ... chief financial officer, is scheduled to present a company overview ... in Las Vegas on Tuesday, May 10th at 10:00 a.m. ... The presentation will be webcast live and can be accessed ...
... May 5, 2011 Rochester Medical Corporation (NASDAQ: ... ended March 31, 2011. The Company reported record ... for the second quarter of last year.  It also reported ... to net loss of ($351,000) or ($0.03) per diluted share ...
Cached Medicine Technology:Rochester Medical Reports Second Quarter Results 2Rochester Medical Reports Second Quarter Results 3Rochester Medical Reports Second Quarter Results 4Rochester Medical Reports Second Quarter Results 5Rochester Medical Reports Second Quarter Results 6Rochester Medical Reports Second Quarter Results 7Rochester Medical Reports Second Quarter Results 8Rochester Medical Reports Second Quarter Results 9Rochester Medical Reports Second Quarter Results 10
... The PalmScan A2000 A-Scan [i.e., PalmScan A2000] ... biometer, which incorporates A-mode pulsed-echo ultrasound,technology, and ... the axial length (AL), anterior,chamber depth (ACD), ... This PalmScan A2000,device is also intended for ...
... TOX/See™ is a 1-step, hand-held, point-of-care device for ... in human urine. The TOX/See device can ... abused drugs in 3 to 8 minutes and ... TOX/See cassette is individually packaged to maximize convenience ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
... device for the qualitative detection of drug or ... device can detect up to nine of the ... minutes and requires only a few drops of ... maximize convenience and ease of use. TOX/See features ...
Medicine Products: